🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multi-center, prospective non-interventional study to collect data on the e...
Status
Terminated
Location
Banner Health MD Anderson Cancer Center
Start Date
2023-09-15
Trial ID
NCT06026332
Treatments Being Tested
The primary purpose of this trial is to evaluate the safety \& tolerability...
Status
Recruiting
Location
Mayo Clinic - Scottsdale Arizona
Start Date
2025-06-12
Trial ID
NCT06668493
Treatments Being Tested
In this phase 4 trial (000439), subjects with NMIBC CIS (± high-grade Ta/T1...
Status
Withdrawn
Location
Ferring Investigational Site
Start Date
2024-06-17
Trial ID
NCT06390111
Treatments Being Tested
This phase II trial tests the effect of intravesical nadofaragene firadenov...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07332351
Previous multi-dose Phase I and Phase II clinical studies have demonstrated...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2016-09-19
Trial ID
NCT02773849
Treatments Being Tested
A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Ob...
Status
Recruiting
Location
University of South Alabama (USA) Health System - USACM
Start Date
2024-10-01
Trial ID
NCT06510374
Treatments Being Tested
The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadof...
Status
Recruiting
Location
Center for Neurosciences
Start Date
2024-10-01
Trial ID
NCT06545955
Treatments Being Tested